Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...

Fintel reports that on February 5, 2025, Wells Fargo initiated coverage of CoStar Group (NasdaqGS:CSGP) with a Underweight ...

AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports ...

Discover why Wells Fargo & Co.'s 7.50% Non-Cumulative Perpetual Convertible Preferred Stock, Series L is a compelling pick.

Wells Fargo analyst Steven Cahall maintained a Buy rating on Fox (FOXA – Research Report) yesterday and set a price target of $59.00. The ...

Wells Fargo downgraded Snap stock to equal weight today despite its Q4 earnings coming in ahead of Street estimates.

In a report released today, Ken Gawrelski from Wells Fargo maintained a Hold rating on Alphabet Class A (GOOGL – Research Report), with a price ...

Fintel reports that on February 5, 2025, Wells Fargo downgraded their outlook for Snap (NYSE:SNAP) from Overweight to ...

Wells Fargo has recently initiated ORIC Pharmaceuticals Inc (ORIC) stock to Overweight rating, as announced on October 31, 2024, according to Finviz. Earlier, on September 6, 2024, Stifel had ...

T Rowe Price Group Inc (TROW) stock saw a modest uptick, ending the day at $115.55 which represents a slight increase of $0.28 or 0.24% from the prior close of $115.27. The stock opened at $115.1 and ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $160.0 to $175.0 for Procter & Gamble over the recent three months. Looking at ...

Financial writer believes PayPal's recent sell-off is unjustified, sees potential for share repurchases and considers company ...